Position in BIIB
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$172,848
+$26,184 QoQ
Shares Held
800
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#770
of 1,031 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Centennial Bank/AR/ holds $4,609,964 across 11 Drug Manufacturers - General names. BIIB ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,788 | $1,216,008 | |
| 2 | MRK |
Merck & Co., Inc.
|
7,051 | $906,053 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
9,469 | $545,603 | |
| 4 | AMGN |
Amgen Inc
|
1,492 | $540,283 | |
| 5 | LLY |
ELI LILLY & Co
|
423 | $507,358 | |
| 6 | ABBV |
AbbVie Inc.
|
1,481 | $372,678 | |
| 7 | BIIB |
Biogen Inc.
This page
|
800 | $172,848 | |
| 8 | PFE |
Pfizer Inc
|
7,108 | $171,160 |
All Filings in BIIB
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,848 | 800 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $146,664 | 800 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $140,792 | 800 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $112,064 | 800 | Shares | Sole | 2025-11-07 | |
| 2025-03-31 | $109,472 | 800 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $122,336 | 800 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $155,072 | 800 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $185,456 | 800 | Shares | Sole | 2024-08-30 | |
| 2024-03-31 | $172,504 | 800 | Shares | Sole | 2024-08-30 | |
| 2023-09-30 | $205,608 | 800 | Shares | Sole | 2024-08-28 | |
| 2023-06-30 | $327,577 | 1,150 | Shares | Sole | 2024-08-28 | |
| 2023-03-31 | $319,734 | 1,150 | Shares | Sole | 2024-08-28 | |
| No filing history on record for this holder in this stock. | ||||||